glp-1 agonists vs bariatric surgery weight loss comparison GLP-1RAs offer comparable to with fewer side effects Bariatric Surgery vs GLP1 Receptor

This finding was consistent for cardiovascular mortality (HR 0.90, 95% CI from 0.50 to 1.61) and all-cause mortality (HR 0.80, 95% CI from 0.51 to 1.25)

Can they help with cholesterol

Several studies have shown that tirzepatide reduces insulin resistance, improves glycemic control, and lowers inflammatory biomarkers, including C-reactive protein and IL-6 (46, 47)

doi: 10.1016/j.mce.2008.11.018 81 KnudsenLBAgersoeHHuusfeldtPONielsenPFWilkenM

Interestingly, certain classical inflammatory stimuliincluding lipopolysaccharide (LPS) and pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor- (TNF-) can, in turn, induce GLP-1 secretion

Kim, J., Farchione, T., Potter, A., Chen, Q